Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 7/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | LIPE | Q05469 | 4/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080327 | 1.00 | HIF1A (0.49) | HIF1ASCN9ALMNALIPEMRGPRX4 | |
| SCHEMBL5076415 | 0.92 | HIF1A (0.59) | HIF1ALMNALIPEMRGPRX4KMT2A | |
| SCHEMBL6151255 | 0.91 | HIF1A (0.49) | HIF1ALMNALIPEMRGPRX4KMT2A | |
| SCHEMBL6151253 | 0.91 | HIF1A (0.49) | HIF1ALMNALIPEMRGPRX4KMT2A | |
| SCHEMBL5077016 | 0.89 | HIF1A (0.52) | HIF1AMRGPRX4 | |
| SCHEMBL5077022 | 0.89 | HIF1A (0.52) | HIF1AMRGPRX4 | |
| SCHEMBL8371691 | 0.86 | HIF1A (0.51) | HIF1ASCN9ALMNALIPEMRGPRX4 | |
| SCHEMBL8780155 | 0.86 | HIF1A (0.51) | HIF1ASCN9ALMNALIPEMRGPRX4 | |
| SCHEMBL8371689 | 0.86 | HIF1A (0.51) | HIF1ASCN9ALMNALIPEMRGPRX4 | |
| SCHEMBL5079438 | 0.84 | HIF1A (0.51) | HIF1ASCN9ALMNAMRGPRX4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
| EP-1494991-A1 | ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES | Isagro Ricerca S.r.l. (IT) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003087032-A1 | ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES | ISAGRO RICERCA S.R.L. (IT) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | HIF1A 4554/4885SCN9A 1765/4885LMNA 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.